Connect with Isoray during ABS 2017
Brachytherapy in the Era of Value-Based Care: An ABS Luncheon
Thursday, April 20th at 11:30AM
Brachytherapy in the era of value-based medicine: are your top referrers hiding in plain sight?
We invite you to join us join us for lunch to discuss brachytherapy in the era of value-based medicine. The presentation will include perspectives from patients, physicians, industry & healthcare marketing. The discussion will provide a holistic look at the alignment opportunities and tactics to communicate the value of brachytherapy.
Industry expert panelists:
- Alex Hsi, Radiation Oncologist at Peninsula Cancer Center
- Michael Krachon, former Chairman, Coalition for the Advancement of Brachytherapy, VP Sales and Marketing Isoray Medical
- Paul Snyder, VP Healthcare, Write2Market
The Fight Against Gynecological Cancer: An Evening Dinner Presentation
Thursday, April 20th at 7PM
Radiation Oncologists Use Brachytherapy to Lead the Fight Against Gynecologic Cancer.
Join Isoray as we host Dr. Jonathan Feddock, Assistant Professor of Radiation Medicine for the University of Kentucky Healthcare. He will discuss his recent successes with Cesium-131 in the treatment of gynecological cancers. This presentation on Permanent Interstitial Brachytherapy will provide some insight on techniques that prove useful to oncologist treating recurrent gynecological cancers.
“I am a huge believer in Brachytherapy. It is the best option in treating prostate cancer.”Dr. Steven Kurtzman, MD
“Perminent Interstitial Brachytherapy with Cesium-131 should atleast be considered for any woman presented with a local recurrence of gynecological cancer.”Dr. Jonathan Feddock, MD